- 2. The  designation  shall  constitute  the  authorised  representative's  mandate,  it  shall  be  valid  only  when  accepted  in writing by the authorised representative and shall be effective at least for all devices of the same generic device group.
- 3. The  authorised  representative shall  perform  the  tasks specified  in  the  mandate  agreed  between  it  and  the manufacturer.  The  authorised  representative  shall  provide  a  copy  of  the  mandate  to  the  competent  authority,  upon request.
The  mandate  shall  require,  and  the  manufacturer  shall  enable,  the  authorised  representative  to  perform  at  least  the following tasks in relation to the devices that it covers:
- (a)   verify  that  the  EU  declaration  of  conformity  and  technical  documentation  have  been  drawn  up  and,  where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;
- (b)   keep  available  a  copy  of  the  technical  documentation,  the  EU  declaration  of  conformity  and,  if  applicable,  a  copy of the  relevant  certificate,  including  any  amendments  and  supplements,  issued  in  accordance  with  Article  56,  at  the disposal of competent authorities for  the period referred to in Article 10(8);
- (c)   comply with the registration obligations laid down in Article 31 and verify that the manufacturer has complied with the registration obligations laid down in Articles 27 and 29; - (d)   in  response  to  a  request  from  a  competent  authority,  provide  that  competent  authority  with  all  the  information  and documentation  necessary  to  demonstrate  the  conformity  of  a  device,  in  an  official  Union  language  determined  by the Member State concerned;
- (e) forward to the manufacturer any request by a competent authority of the Member State in which the authorised rep­ resentative  has  its  registered  place  of  business  for  samples,  or  access  to  a  device  and  verify  that  the  competent authority receives the samples or is given access to the device;
- (f) cooperate  with  the  competent  authorities  on  any  preventive  or  corrective  action  taken  to  eliminate  or,  if  that  is  not possible, mitigate the risks posed by devices;
- (g)   immediately  inform  the  manufacturer  about  complaints  and  reports  from  healthcare  professionals,  patients  and users about suspected incidents related to a device for  which they have been designated;
- (h)   terminate the mandate if  the manufacturer acts contrary to its obligations under  this Regulation.
- 4. The mandate referred to in paragraph 3 of  this  Article  shall  not  delegate  the  manufacturer's  obligations  laid  down in Article 10(1), (2), (3), (4), (6), (7), (9), (10), (11) and (12).
- 5. Without prejudice to paragraph 4 of this Article, where the manufacturer is not established in a Member State and has  not  complied  with  the  obligations  laid  down  in  Article  10,  the  authorised  representative  shall  be  legally  liable  for defective devices on the same basis as, and jointly and severally with, the manufacturer.
- 6. An  authorised  representative  who  terminates  its  mandate  on  the  ground  referred  to  in  point  (h)  of  paragraph  3 shall  immediately  inform  the  competent  authority of  the  Member  State  in  which  it  is  established  and,  where  applicable, the  notified  body  that  was  involved  in  the  conformity  assessment  for  the  device  of  the  termination  of  the  mandate  and the reasons therefor.
- 7. Any  reference  in  this  Regulation  to  the  competent  authority  of  the  Member  State  in  which  the  manufacturer  has its  registered  place  of  business  shall  be  understood  as  a  reference  to  the  competent  authority  of  the  Member  State  in which the authorised  representative,  designated  by  a  manufacturer  referred  to  in  paragraph  1,  has  its  registered  place  of business.
## Article 12
## Change of authorised representative
The detailed arrangements for a change of authorised representative shall be clearly defined in an agreement between the manufacturer,  where  practicable  the  outgoing  authorised  representative,  and  the  incoming  authorised  representative. That agreement shall address at least the following aspects:
- (a)   the  date  of  termination  of  the  mandate  of  the  outgoing  authorised  representative  and  date  of  beginning  of  the mandate of the incoming authorised representative;
- (b)   the  date  until  which  the  outgoing  authorised  representative  may  be  indicated  in  the  information  supplied  by  the manufacturer, including any promotional material;
- (c)   the  transfer of documents, including confidentiality aspects and property rights;
- (d)   the obligation of the outgoing authorised representative after the end of the mandate to forward to the manufacturer  or  incoming  authorised  representative  any  complaints  or reports from  healthcare  professionals, patients  or  users  about  suspected  incidents  related  to  a  device  for  which  it  had  been  designated  as  authorised  rep­ resentative.
## Article 13
## General obligations of  importers
- 1. Importers shall place on the Union market only devices that are in conformity with this Regulation.
- 2. In order  to place a device on the market, importers shall verify that:
- (a)   the  device has been CE marked and that the EU declaration of conformity of the device has been drawn up;
- (b)   a  manufacturer  is  identified  and  that  an  authorised  representative  in  accordance  with  Article  11  has  been  designated by the manufacturer;
- (c)   the  device is labelled in accordance with this Regulation and accompanied by the required instructions for use;
- (d)   where applicable, a UDI has been assigned by the manufacturer in accordance with Article 27. Where  an  importer  considers  or  has  reason  to  believe  that  a  device  is  not  in  conformity  with  the  requirements  of  this Regulation,  it  shall  not  place  the  device  on  the  market  until  it  has  been  brought  into  conformity  and  shall  inform  the manufacturer  and  the  manufacturer's  authorised  representative.  